Skip to main content
. 2019 Nov 27;9:17658. doi: 10.1038/s41598-019-54227-6

Figure 3.

Figure 3

Hazard ratios (95% confidence interval) for risks of progression to ESRD and all-cause mortality using coarsened exact matching analysis for 1-, 2-, 3-, 4-, and 5-year and overall follow-up period comparing patients with AKIOPT versus non-AKIOPT before pre-dialysis program enrollment.